This document provides a summary of key points from the literature, guidelines or other documents from experts on the subject matter, including from national and multilateral organizations and authorities. This document does not aim to be exhaustive. Due to the rapidly evolving situation, this summary document may not include latest evidence and updates are likely. New versions will be issued when significant new information becomes available. Its purpose is to support organizations and institutions involved in the development of COVID-19 vaccines. It is the responsibility of each vaccine developer to review available evidence, take into account relevant guidance and recommendations, and to seek scientific advice from regulatory agencies as appropriate.
Prepared By: Amol Chaudhari for CEPI COVID-19 Clinical Working Group
For questions, please write to: amol.chaudhari@cepi.net
Please Sign in (or Register) to view further.